Consolidated Balance Sheet (Unaudited) (Parenthetical) - USD ($) $ in Thousands		Mar. 31, 2023	Dec. 31, 2022
Investments at amortized cost	[1],[2],[3],[4]	$ 1,248,920
Deferred financing costs		$ 11,357	$ 3,911
Common shares, par value		$ 0.001	$ 0.001
Common shares, issued		31,525,841	21,882,028
Common shares, outstanding		31,525,841	21,882,028
Non-controlled, Non-affiliated Investments
Investments at amortized cost		$ 1,248,920	$ 809,029

[1] As of March 31, 2023, the estimated cost basis of investments for U.S. federal tax purposes was $1,253,875 resulting in estimated gross unrealized gains and losses of $17,007 and $10,578, respectfully.

[2] Certain portfolio company investments are subject to contractual restrictions on sales.

[3] The amortized cost represents the original cost adjusted for the amortization of discounts and premiums, as applicable, on debt investments using the effective interest method.

[4] Unless otherwise indicated, the Company’s portfolio companies are domiciled in the United States. Under the Investment Company Act of 1940, as amended (the “1940 Act”), the Company would “control” a portfolio company if the Company owned
more than 25% of its outstanding voting securities and/or had the power to exercise control over the management or policies of
such portfolio company. As of March 31, 2023, the Company does not “control” any of the portfolio companies. Also under the 1940 Act, the Company would be deemed to be an “Affiliated Person” of a portfolio company if the Company owns more than 5% of the portfolio company's outstanding voting securities. As of March 31, 2023, the Company does not identify any of its portfolio companies as affiliates.